Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 321

1.

Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.

Bandelow B, Behnke K, Lenoir S, Hendriks GJ, Alkin T, Goebel C, Clary CM.

J Clin Psychiatry. 2004 Mar;65(3):405-13.

PMID:
15096081
[PubMed - indexed for MEDLINE]
2.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
3.

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y.

Psychopharmacology (Berl). 2007 Oct;194(2):233-42. Epub 2007 Jun 23. Erratum in: Psychopharmacology (Berl). 2008 Feb;196(2):339. Zhang, Ying [added].

PMID:
17589833
[PubMed - indexed for MEDLINE]
4.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
[PubMed - indexed for MEDLINE]
5.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group.

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
[PubMed - indexed for MEDLINE]
6.

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R.

Arch Gen Psychiatry. 1998 Nov;55(11):1010-6.

PMID:
9819070
[PubMed - indexed for MEDLINE]
7.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
[PubMed - indexed for MEDLINE]
8.

Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.

Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM.

J Psychiatr Res. 2002 Jul-Aug;36(4):229-36.

PMID:
12191627
[PubMed - indexed for MEDLINE]
9.

Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.

Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW.

J Clin Psychiatry. 2005 Jan;66(1):94-9.

PMID:
15669894
[PubMed - indexed for MEDLINE]
10.

Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.

Lepola U, Arató M, Zhu Y, Austin C.

J Clin Psychiatry. 2003 Jun;64(6):654-62.

PMID:
12823079
[PubMed - indexed for MEDLINE]
11.

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM.

J Clin Psychiatry. 2003 Jul;64(7):785-92.

PMID:
12934979
[PubMed - indexed for MEDLINE]
12.

A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.

Kamijima K, Kuboki T, Kumano H, Burt T, Cohen G, Arano I, Hamasaki T.

Int Clin Psychopharmacol. 2005 Sep;20(5):265-73.

PMID:
16096517
[PubMed - indexed for MEDLINE]
13.

Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.

Miner CM, Brown EB, Gonzales JS, Munir R.

J Clin Psychiatry. 2002 Mar;63(3):232-40.

PMID:
11926723
[PubMed - indexed for MEDLINE]
14.

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.

Am J Psychiatry. 1998 Jan;155(1):36-42.

PMID:
9433336
[PubMed - indexed for MEDLINE]
15.

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.

Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM.

Am J Psychiatry. 2004 Sep;161(9):1642-9.

PMID:
15337655
[PubMed - indexed for MEDLINE]
16.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
[PubMed - indexed for MEDLINE]
17.
18.

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C.

J Clin Psychiatry. 2006 Jan;67(1):15-22.

PMID:
16426083
[PubMed - indexed for MEDLINE]
19.

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

Pohl RB, Wolkow RM, Clary CM.

Am J Psychiatry. 1998 Sep;155(9):1189-95.

PMID:
9734541
[PubMed - indexed for MEDLINE]
20.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk